25. Double synergic chitosan-coated poly (lactic- co-glycolic) acid nanospheres loaded with nucleic acids as an intranasally administered vaccine delivery system to control the infection of foot- and-mouth disease virus. Link 26. Evaluation of Swine Protection with Three Commercial Foot-and-Mouth Disease Vaccines against Heterologous Challenge with Type A ASIA/ G-VII Lineage Viruses. Link 27. Leaderless foot-and-mouth disease virus serotype O did not cause clinical disease and failed to establish a persistent infection in cattle. Link 28. Foot-and-mouth disease-associated myocarditis is age dependent in suckling calves PPRV. Link 29. Carboplatin restricts peste des petits ruminants virus replication by suppressing the STINGmediated autophagy. Link 30. Picornavirus VP3 protein induces autophagy through the TP53-BAD-BAX axis to promote viral replication. Link 31. Analysis of Acute Phase Response Using Acute Phase Proteins Following Simultaneous Vaccination of Lumpy Skin Disease and Foot-and- Mouth Disease. Link 32. The pseudoknot region and poly-(C) tract comprise an essential RNA packaging signal for assembly of foot-and-mouth disease virus. Link 33. Stearoyl coenzyme A desaturase 1 (SCD1) regulates foot-and-mouth disease virus replication by modulating host cell lipid metabolism and 2C-mediated replication complex formation. Link 34. Machine learning approaches for estimating cross-neutralization potential among FMD serotype O viruses. Link 35. A Comprehensive Review of Our Understanding and Challenges of Viral Vaccines against Swine Pathogens. Link
36. Monoclonal antibody based solid phase competition ELISA to detect FMDV serotype A specific antibodies. Link 37. Epidemiological investigation of foot-and- mouth disease outbreaks in a Vietnamese bear rescue centre. Link
38. Foot and mouth disease vaccine efficacy in Africa: a systematic review and meta-analysis. Link
39. Critically appraised topic: the use of vaccination to control the spread of foot-and-mouth disease in Australian livestock in the event of an incursion. Link
40. Foot and mouth disease vaccine efficacy in Africa: a systematic review and meta-analysis. Link
41. Complete coding region sequence analyses and antigenic characterization of emerging lineage G-IX of foot- and-mouth disease virus serotype Asia1. Link 42. Why Foot-and-Mouth Disease-Free with Vaccination Should Be Equivalent to Foot-and- Mouth Disease-Free without Vaccination. Link 43. An IgG1 single-dilution avidity ELISA predicts cross-protection against heterologous foot-and- mouth disease virus challenge after vaccination 44. Foot and Mouth Disease Vaccine Matching and Post-Vaccination Assessment in Abu Dhabi, United Arab Emirates. Link 45. Epidemiological Study Of Foot And Mouth Diseases Through Serological And Molecular Investigation In Cattle Of Selected Districts, Jimma Zone, Southwest Ethiopia. Link 46. The Pathogenesis of Foot-and-Mouth Disease Virus Infection: How the Virus Escapes from Immune Recognition and Elimination 47. Defining Correlates of Protection for Mammalian Livestock Vaccines Against High Priority Viral Diseases. Link
25
Made with FlippingBook flipbook maker